Editorial: The US burden of HRS-AKI-Putting numbers to the problem: Authors' reply
- PMID: 37307544
- DOI: 10.1111/apt.17562
Editorial: The US burden of HRS-AKI-Putting numbers to the problem: Authors' reply
Comment on
-
Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis-related hospitalisations in the US.Aliment Pharmacol Ther. 2022 Nov;56(10):1486-1496. doi: 10.1111/apt.17232. Epub 2022 Oct 5. Aliment Pharmacol Ther. 2022. PMID: 36196562
-
Editorial: The US burden of HRS-AKI-Putting numbers to the problem.Aliment Pharmacol Ther. 2023 Jul;58(1):120-121. doi: 10.1111/apt.17541. Aliment Pharmacol Ther. 2023. PMID: 37307546 No abstract available.
References
REFERENCES
-
- Frager SZ, Sigal SH. Editorial: the US burden of HRS-AKI- putting numbers to the problem. Aliment Pharmacol Ther. 2023;58:120-1.
-
- Singal AK, Kuo YF, Reddy KR, Bataller R, Kwo P. Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis-related hospitalisations in the US. Aliment Pharmacol Ther. 2022;56:1486-96.
-
- Khera R, Krumholz HM. With great power comes great responsibility: big data research from the National Inpatient Sample. Circ Cardiovasc Qual Outcomes. 2017;10:10.
-
- Tariq R, Hadi Y, Chahal K, Reddy S, Salameh H, Singal AK. Incidence, mortality and predictors of acute kidney injury in patients with cirrhosis: a systematic review and meta-analysis. J Clin Transl Hepatol. 2020;8:135-42.
-
- Yasui K, Sumida Y, Mori Y, Mitsuyoshi H, Minami M, Itoh Y, et al. Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. Metabolism. 2011;60:735-9.